These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome. George CF, Feldman N, Zheng Y, Steininger TL, Grzeschik SM, Lai C, Inhaber N. Sleep Breath; 2011 Jan; 15(1):13-20. PubMed ID: 20082240 [Abstract] [Full Text] [Related]
4. A safety trial of sodium oxybate in patients with obstructive sleep apnea: Acute effects on sleep-disordered breathing. George CF, Feldman N, Inhaber N, Steininger TL, Grzeschik SM, Lai C, Zheng Y. Sleep Med; 2010 Jan; 11(1):38-42. PubMed ID: 19897413 [Abstract] [Full Text] [Related]
5. Rigorous study of Xyrem®/sodium oxybate use among patients with obstructive sleep apnea and other conditions of compromised respiratory function is critically needed. Zvosec DL, Smith SW, Mahowald MW. Sleep Med; 2011 Jan; 12(1):103-4; author reply 104-5. PubMed ID: 20643578 [No Abstract] [Full Text] [Related]
6. Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial. Büchele F, Hackius M, Schreglmann SR, Omlor W, Werth E, Maric A, Imbach LL, Hägele-Link S, Waldvogel D, Baumann CR. JAMA Neurol; 2018 Jan 01; 75(1):114-118. PubMed ID: 29114733 [Abstract] [Full Text] [Related]
7. Problems with latest Xyrem group investigation. Hudgel DW. J Clin Sleep Med; 2006 Jan 15; 2(1):96; author reply 97. PubMed ID: 17557445 [No Abstract] [Full Text] [Related]
8. Long-term follow-up of patients with narcolepsy-cataplexy treated with sodium oxybate (Xyrem). Alshaikh MK, Gacuan D, George S, Sharif M, Bahammam AS. Clin Neuropharmacol; 2011 Jan 15; 34(1):1-4. PubMed ID: 21206362 [Abstract] [Full Text] [Related]
10. Increase in sleep-related breathing disturbances after treatment with sodium oxybate in patients with narcolepsy and mild obstructive sleep apnea syndrome: two case reports. Seeck-Hirschner M, Baier PC, von Freier A, Aldenhoff J, Göder R. Sleep Med; 2009 Jan 15; 10(1):154-5. PubMed ID: 18226949 [No Abstract] [Full Text] [Related]
11. Successful treatment of REM sleep behavior disorder with sodium oxybate. Shneerson JM. Clin Neuropharmacol; 2009 Jan 15; 32(3):158-9. PubMed ID: 19483483 [Abstract] [Full Text] [Related]
12. Clinical perspective: monitoring sodium oxybate-treated narcolepsy patients for the development of sleep-disordered breathing. Feldman NT. Sleep Breath; 2010 Feb 15; 14(1):77-9. PubMed ID: 19626356 [Abstract] [Full Text] [Related]
13. Response to Editorial: "Xyrem safety: The debate continues". Zvosec DL, Smith SW. Sleep Med; 2010 Jan 15; 11(1):108; author reply 108-9. PubMed ID: 19959395 [No Abstract] [Full Text] [Related]
18. The use of sodium oxybate to treat narcolepsy. Mayer G. Expert Rev Neurother; 2012 May 05; 12(5):519-29. PubMed ID: 22550980 [Abstract] [Full Text] [Related]
19. Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study. Moldofsky H, Inhaber NH, Guinta DR, Alvarez-Horine SB. J Rheumatol; 2010 Oct 05; 37(10):2156-66. PubMed ID: 20682669 [Abstract] [Full Text] [Related]
20. Improved sleep and neurocognitive functions in a child with thalamic lesions on sodium oxybate. Kothare SV, Adams R, Valencia I, Faerber EC, Grant ML. Neurology; 2007 Apr 03; 68(14):1157-8. PubMed ID: 17404202 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]